Severe combined immunodeficiency is seen with:
## **Core Concept**
Severe combined immunodeficiency (SCID) refers to a group of rare, sometimes fatal, congenital disorders characterized by little or no immune response. These disorders result from defects in one or more of the key components of the immune system, including T cells, B cells, and natural killer (NK) cells. SCID conditions are often caused by genetic mutations affecting the development or function of these immune cells.
## **Why the Correct Answer is Right**
The correct answer involves understanding the specific genetic defects that lead to SCID. One of the most common causes of SCID is a deficiency in the enzyme **adenosine deaminase (ADA)**, which is crucial for purine metabolism. Without ADA, toxic metabolites accumulate in lymphocytes (T cells and B cells), leading to their destruction and resulting in severe immunodeficiency. This condition is known as **ADA-SCID** and is characterized by a significant reduction in T cells, B cells, and sometimes NK cells.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might refer to another immunodeficiency condition but is not specified. Without specifics, it's hard to directly refute, but given the context, it's less directly related to SCID than the correct answer.
- **Option B:** Similarly, this could refer to another condition. Common variable immunodeficiency (CVID) or other specific immunodeficiencies might be considered here, but they do not represent SCID.
- **Option C:** This might refer to conditions affecting the immune system but is not directly linked to SCID.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **SCID patients often present early in life with recurrent severe infections**, which can include pneumonia, diarrhea, and failure to thrive. A critical aspect of management is **bone marrow transplantation (BMT)**, which can cure some forms of SCID, including ADA-SCID. Early diagnosis through newborn screening programs for SCID, which may include testing for low T-cell receptor excision circles (TRECs), has significantly improved outcomes.
## **Correct Answer: D. ADA deficiency.**